Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Diannaa
(improve mark-up)
m (131 revisions imported)
 
(27 intermediate revisions by 19 users not shown)
Line 1: Line 1:
 
{{Navbox
 
{{Navbox
| name = Antithrombotics
+
| name = Antithrombotics
| title = [[Antithrombotic]]s ([[thrombolytic drug|thrombolytics]], [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]])
+
| title = [[Antithrombotic]]s ([[Thrombolytic drug|thrombolytics]], [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]])
| listclass = hlist
+
| state = {{{state<includeonly>|autocollapse</includeonly>}}}
| groupstyle = background:MistyRose;
+
| bodyclass = hlist
  
| group1 = [[Antiplatelet drug]]s
+
| group1 = [[Antiplatelet drug]]s
| list1 = {{Navbox subgroup
+
| list1 = {{Navbox|child
  | groupstyle = background-color: MistyRose
 
  
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
+
  | group1 = [[Glycoprotein IIb/IIIa inhibitors]]
| list1 =
+
  | list1 =
 
* [[Abciximab]]
 
* [[Abciximab]]
 
* [[Eptifibatide]]
 
* [[Eptifibatide]]
 +
* [[Orbofiban]]
 +
* [[Roxifiban]]
 +
* [[Sibrafiban]]<sup>§</sup>
 
* [[Tirofiban]]
 
* [[Tirofiban]]
  
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
+
  | group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
| list2 =
+
  | list2 =
* ''[[thienopyridine]]s''
+
* [[Thienopyridine]]s
 
** [[Clopidogrel]]
 
** [[Clopidogrel]]
 
** [[Prasugrel]]
 
** [[Prasugrel]]
 
** [[Ticlopidine]]
 
** [[Ticlopidine]]
* ''[[nucleotide]]/[[nucleoside]] analogs''
+
* [[Nucleotide]]/[[nucleoside]] analogs
 
** [[Cangrelor]]
 
** [[Cangrelor]]
 
** [[Elinogrel]]
 
** [[Elinogrel]]
 
** [[Ticagrelor]]
 
** [[Ticagrelor]]
  
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
+
  | group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
| list3 =
+
  | list3 =
 
* [[Beraprost]]
 
* [[Beraprost]]
 +
* [[Iloprost]]
 
* [[Prostacyclin]]
 
* [[Prostacyclin]]
* [[Iloprost]]
 
 
* [[Treprostinil]]
 
* [[Treprostinil]]
  
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
+
  | group4 = [[Mechanism of action of aspirin|COX inhibitors]]
| list4 =
+
  | list4 =
 
* [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>
 
* [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>
 
* [[Aloxiprin]]
 
* [[Aloxiprin]]
Line 41: Line 43:
 
* [[Triflusal]]
 
* [[Triflusal]]
  
| group5 = [[Thromboxane inhibitors]]
+
  | group5 = [[Thromboxane inhibitors]]
| list5 =
+
  | list5 =
* ''[[thromboxane synthase inhibitors]]''
+
* [[Thromboxane synthase inhibitors]]
** [[Dipyridamole]]
+
** [[Dipyridamole]] ([[Acetylsalicylic acid/dipyridamole|+ aspirin]])
 
** [[Picotamide]]
 
** [[Picotamide]]
 +
** [[Terbogrel]]
 +
* [[Thromboxane receptor antagonist|Receptor antagonist]]s
 +
** [[Terbogrel]]
 +
** [[Terutroban]]<sup>§</sup>
  
* ''[[Thromboxane receptor antagonist|receptor antagonist]]''
+
  | group6 = [[Phosphodiesterase inhibitor]]s
** [[Terutroban]]<sup>†</sup>
+
  | list6 =
 
 
| group6 = [[Phosphodiesterase inhibitor]]s
 
| list6 =
 
 
* [[Cilostazol]]
 
* [[Cilostazol]]
 
* [[Dipyridamole]]
 
* [[Dipyridamole]]
 
* [[Triflusal]]
 
* [[Triflusal]]
  
| group7 = Other
+
  | group7 = Other
| list7 =
+
  | list7 =
 
* [[Cloricromen]]
 
* [[Cloricromen]]
 
* [[Ditazole]]
 
* [[Ditazole]]
}}
+
* [[Vorapaxar]]
 +
 
 +
}}
  
| group2 = [[Anticoagulant]]s
+
| group2 = [[Anticoagulant]]s
| list2 = {{Navbox subgroup
+
| list2 = {{Navbox|child
  | groupstyle = background-color: MistyRose
+
  | evenodd = swap
  
  | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
+
  | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
  | list1 =
+
  | list1 =
* ''[[coumarin]]s:'' [[Acenocoumarol]]
+
* [[Coumarin]]s: [[Acenocoumarol]]
 
* [[Coumatetralyl]]
 
* [[Coumatetralyl]]
 
* [[Dicoumarol]]
 
* [[Dicoumarol]]
Line 74: Line 79:
 
* [[Phenprocoumon]]
 
* [[Phenprocoumon]]
 
* [[Warfarin]]<sup>#</sup>
 
* [[Warfarin]]<sup>#</sup>
 
+
* [[1,3-Indandione]]s: [[Clorindione]]
*''[[1,3-Indandione]]s:'' [[Clorindione]]
 
 
* [[Diphenadione]]
 
* [[Diphenadione]]
 
* [[Phenindione]]
 
* [[Phenindione]]
 +
* Other: [[Tioclomarol]]
  
* ''other:'' [[Tioclomarol]]
+
  | group2 = [[Factor Xa]] inhibitors<br />(with some II inhibition)
 
+
  | list2 = {{Navbox|child
| group2 = [[Factor Xa]] inhibitors<br />(with some II inhibition)
 
| list2 = {{Navbox subgroup
 
  | groupstyle = background-color: MistyRose
 
  
| group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
+
    | group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
| list1 =
+
    | list1 =
* ''[[low-molecular-weight heparin]]''
+
* [[Low-molecular-weight heparin]]
 
** [[Bemiparin sodium|Bemiparin]]
 
** [[Bemiparin sodium|Bemiparin]]
 
** [[Certoparin sodium|Certoparin]]
 
** [[Certoparin sodium|Certoparin]]
Line 96: Line 98:
 
** [[Reviparin sodium|Reviparin]]
 
** [[Reviparin sodium|Reviparin]]
 
** [[Tinzaparin sodium|Tinzaparin]]
 
** [[Tinzaparin sodium|Tinzaparin]]
 
+
* [[Oligosaccharide]]s
* ''[[oligosaccharide]]s''
 
 
** [[Fondaparinux]]
 
** [[Fondaparinux]]
** [[Idraparinux]]
+
** [[Idraparinux]]<sup>§</sup>
 
+
* [[Heparinoid]]s
* ''[[heparinoid]]''
 
 
** [[Danaparoid]]
 
** [[Danaparoid]]
 +
** [[Dermatan sulfate]]
 
** [[Sulodexide]]
 
** [[Sulodexide]]
** [[Dermatan sulfate]]
 
  
| group7 = [[Direct Xa inhibitor]]s
+
    | group2 = [[Direct Xa inhibitor]]s ("xabans")
| list7 =
+
    | list2 =
* ''xabans''
+
* [[Apixaban]]
** [[Apixaban]]
+
* [[Betrixaban]]
** [[Betrixaban]]
+
* [[Darexaban]]<sup>§</sup>
 
* [[Edoxaban]]
 
* [[Edoxaban]]
** [[Otamixaban]]
+
* [[Otamixaban]]<sup>§</sup>
** [[Rivaroxaban]]
+
* [[Rivaroxaban]]
}}
+
 
 +
  }}
  
| group6 = [[Direct thrombin inhibitor|Direct thrombin (II) inhibitor]]s
+
<!-- group3 omitted to preserve alternating striping -->
| list6 =
+
 
* ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]]
+
  | group4 = [[Direct thrombin inhibitor|Direct thrombin (IIa) inhibitor]]s
 +
  | list4 =
 +
* [[Direct thrombin inhibitor#Bivalent|Bivalent]]: [[Hirudin]]
 
** [[Bivalirudin]]
 
** [[Bivalirudin]]
 +
** [[Desirudin]]
 
** [[Lepirudin]]
 
** [[Lepirudin]]
** [[Desirudin]]
+
* [[Direct thrombin inhibitor#Univalent|Univalent]]: [[Argatroban]]
 
 
* ''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]
 
 
* [[Dabigatran]]
 
* [[Dabigatran]]
 +
* [[Efegatran]]
 +
* [[Inogatran]]<sup>§</sup>
 
* [[Melagatran]]<sup>‡</sup>
 
* [[Melagatran]]<sup>‡</sup>
 
* [[Ximelagatran]]<sup>‡</sup>
 
* [[Ximelagatran]]<sup>‡</sup>
  
| group8 = Other
+
  | group5 = Other
| list8 =
+
  | list5 =
* [[REG1<!--instantly reversible aptamer-based direct FIXa inhibitor in IIb trials -->]]
+
* [[Antithrombin|Antithrombin III]]
 
* [[Defibrotide]]
 
* [[Defibrotide]]
 +
* [[Protein C]]
 +
** [[Drotrecogin alfa]]<sup>‡</sup>
 
* [[Ramatroban]]
 
* [[Ramatroban]]
* [[Antithrombin|Antithrombin III]]
+
* [[REG1<!--instantly reversible aptamer-based direct FIXa inhibitor in IIb trials -->]]
* [[Protein C]]
+
 
** [[Drotrecogin alfa]]
+
}}
}}
 
  
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
+
| group3 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
| list5 =
+
| list3 =
* ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]''
+
* [[Plasminogen activator]]s: [[Recombinant tissue plasminogen activators|r-tPA]]
** [[Tissue plasminogen activator|Alteplase]]
+
** [[Alteplase]]
 
** [[Reteplase]]
 
** [[Reteplase]]
 
** [[Tenecteplase]]
 
** [[Tenecteplase]]
* ''UPA''
+
** [[Desmoteplase]]<sup>†</sup>
 +
* UPA
 +
** [[Saruplase]]
 
** [[Urokinase]]
 
** [[Urokinase]]
** [[Saruplase]]
 
* [[Streptokinase]]<sup>#</sup>
 
 
* [[Anistreplase]]
 
* [[Anistreplase]]
 
* [[Monteplase]]
 
* [[Monteplase]]
 
+
* [[Streptokinase]]<sup>#</sup>
*''other [[serine endopeptidase]]s:'' [[Ancrod]]
+
* Other [[serine endopeptidase]]s: [[Ancrod]]
 +
* [[Brinase]]
 
* [[Fibrinolysin]]
 
* [[Fibrinolysin]]
* [[Brinase]]
 
  
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
+
| group4 = [[Anticoagulant|Non-medicinal]]
| list8 =
+
| list4 =
 
* [[Citrate]]
 
* [[Citrate]]
* [[EDTA]]
+
* [[Ethylenediaminetetraacetic acid|EDTA]]
 
* [[Oxalate]]
 
* [[Oxalate]]
  
| belowstyle = background: transparent; padding: 0px;
+
| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}}{{Myeloid navs}}
+
| below = {{PharmNavFootnote}}  
  
 
}}<noinclude>
 
}}<noinclude>
[[Category:Antithrombotic agents]]
+
{{collapsible option}}
[[Category:Drug_templates by ATC]]
+
[[Category:Drug templates by ATC]]
[[hu:Sablon:Antitrombotikumok]]
 
[[pt:Predefinição:Antitrombóticos]]
 
[[zh:Template:抗血栓药]]
 
 
</noinclude>
 
</noinclude>

Latest revision as of 14:27, 22 October 2020

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Antithrombotics|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Antithrombotics|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Antithrombotics|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.